2014
DOI: 10.3987/rev-14-800
|View full text |Cite
|
Sign up to set email alerts
|

Pyroglutamic Acid Derivatives: Building Blocks for Drug Discovery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 22 publications
(3 citation statements)
references
References 86 publications
0
3
0
Order By: Relevance
“…All other amino acids are secondary ones, because they are formed as a result of the transamination of the amino acids listed above with the corresponding keto acids that arise during the metabolism, as well as by the conversion of some acids to others [58]. The dehydration of glutamic acid leads to the formation of its lactam-pyroglutamic acid, which is the key precursor in the biosynthesis of biologically active compounds of primary and secondary metabolites [59].…”
Section: Discussionmentioning
confidence: 99%
“…All other amino acids are secondary ones, because they are formed as a result of the transamination of the amino acids listed above with the corresponding keto acids that arise during the metabolism, as well as by the conversion of some acids to others [58]. The dehydration of glutamic acid leads to the formation of its lactam-pyroglutamic acid, which is the key precursor in the biosynthesis of biologically active compounds of primary and secondary metabolites [59].…”
Section: Discussionmentioning
confidence: 99%
“…[1,2,24] In particular, 2,6-dimethyl-L-tyrosine (Dmt) and cis-4-amino-L-proline (cAmp) has become one of the most popular nonnatural amino acids for replacing tyrosine, and proline, respectively, in synthetic opioid peptides. [14,25] The structural limitation provided by the two additional methyl groups in Dmt and the additional amino group in proline in cAmp may influence receptor affinity, selectivity, and bioactivity of peptides containing such amino acids. The presence of Dmt in opioid peptides can lead to the design of unique peptidomimetic molecules.…”
Section: Introductionmentioning
confidence: 99%
“…Pyroglutamates are of interest particularly for their role as starting materials and in drug discovery; , we have been interested in the application of pyroglutamic acids as a chiral starting material and have shown that, in a suitably protected form, it may be selectively alkylated, hydroxylated, and aminated, , as well as used for conjugate additions by carbon, oxygen, and nitrogen nucleophiles . While this does provide access to highly functionalized heterocyclic derivatives, it can require sequential activation of different positions around the heterocyclic ring and such a multistep sequence lacks convenience; an approach involving C–H activation for direct ring functionalization has, however, been recently reported .…”
Section: Introductionmentioning
confidence: 99%